MU
Mitsubishi UFJ Capital
Venture CapitalActiveMitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT and high technology investments.
316
Investments
4
Exits
$5.5B
AUM
1.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Mitsubishi UFJ Capital.
Investment Thesis & Strategy
Mitsubishi UFJ Capital invests in life science, ICT, and high technology companies, with a focus on biotech and semiconductor, across various stages of development.
Investment Activity
Deals per year over the last 6 years
1
20174
20181
20191
20203
20212
2022Portfolio Companies
Selected investments from their portfolio of 316 companies
A
AnyMind Group
SaaS · Series C+, 2022
A
Aillis
Healthcare · Series A, 2022
T
Tsuburaya Productions
Media/Content · Growth, 2021
T
TRIPLE-1
Other · Series A, 2021
C
CellSource
Biotech · Growth, 2021
L
LayerX
Fintech · Series A, 2020
C
CureApp
Healthcare · Series C+, 2019
S
Spiber
Biotech · Growth, 2018
S
SmartDrive
Transportation · Series B, 2018
i
iSpace
Other · Series A, 2018
A
Abeja
AI/ML · Series B, 2018
K
Kaizen Platform
SaaS · Series B, 2017
Notable Exits
CompanyTypeYearValue / Acquirer
SpiberAcquisition2025$1.5B
SmartNewsAcquisition2024$2B
SansanIPO2019$600M
MercariIPO2018$1.2B
Frequently Asked Questions
Mitsubishi UFJ Capital focuses on Series A, Series B, Series C+ stage investments.